EyePoint Pharmaceuticals, Inc. (EYPT)
NASDAQ: EYPT · Real-Time Price · USD
8.35
-0.61 (-6.76%)
Nov 21, 2024, 4:00 PM EST - Market closed
EyePoint Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -103.57 | -70.8 | -102.25 | -58.42 | -45.39 | -56.79 | Upgrade
|
| Depreciation & Amortization | 1.19 | 0.46 | 2.45 | 2.77 | 2.65 | 2.6 | Upgrade
|
| Other Amortization | - | - | - | - | 0.75 | 0.6 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | 20.7 | - | - | - | Upgrade
|
| Stock-Based Compensation | 32.43 | 12.06 | 14.18 | 7.45 | 5.55 | 4.57 | Upgrade
|
| Other Operating Activities | -4.58 | 1.27 | 2.95 | -0.16 | 1.88 | 4.86 | Upgrade
|
| Change in Accounts Receivable | -2.38 | 14.43 | -2.66 | -10.6 | 4.85 | -15.3 | Upgrade
|
| Change in Inventory | 1.77 | -1.55 | -0.76 | 1.35 | -3.2 | -1.86 | Upgrade
|
| Change in Accounts Payable | -1.67 | 1.52 | 1.2 | 8.48 | 1.87 | 4.6 | Upgrade
|
| Change in Unearned Revenue | -34.95 | 44.52 | -0.87 | -0.93 | 16.55 | -0.02 | Upgrade
|
| Change in Other Net Operating Assets | -1.72 | -0.04 | 0.07 | -0.03 | 0.07 | 0.05 | Upgrade
|
| Operating Cash Flow | -113.49 | 1.88 | -65.01 | -50.1 | -14.44 | -56.7 | Upgrade
|
| Capital Expenditures | -4.55 | -3.48 | -2.15 | -0.16 | -0.36 | -0.21 | Upgrade
|
| Investment in Securities | -165.99 | 0.17 | -15.12 | -32.97 | - | - | Upgrade
|
| Investing Cash Flow | -170.54 | -3.32 | -17.27 | -33.12 | -0.36 | -0.21 | Upgrade
|
| Short-Term Debt Issued | - | 5.3 | 43.88 | - | - | - | Upgrade
|
| Long-Term Debt Issued | - | - | 30 | - | 2.04 | 50 | Upgrade
|
| Total Debt Issued | - | 5.3 | 73.88 | - | 2.04 | 50 | Upgrade
|
| Short-Term Debt Repaid | - | -15.78 | -33.4 | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -30.04 | -38.37 | -0.15 | -13.84 | -20 | Upgrade
|
| Total Debt Repaid | -0.07 | -45.81 | -71.77 | -0.15 | -13.84 | -20 | Upgrade
|
| Net Debt Issued (Repaid) | -0.07 | -40.51 | 2.1 | -0.15 | -11.8 | 30 | Upgrade
|
| Issuance of Common Stock | 235.75 | 229.55 | 0.4 | 217.2 | 50.21 | 23.04 | Upgrade
|
| Repurchase of Common Stock | -4.51 | -0.17 | -0.3 | -0.15 | -0.09 | -0.12 | Upgrade
|
| Other Financing Activities | -0.34 | -1.8 | -2.89 | - | -0.83 | -19.06 | Upgrade
|
| Financing Cash Flow | 230.82 | 187.07 | -0.69 | 216.9 | 37.49 | 33.86 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | - | - | - | - | 0 | Upgrade
|
| Net Cash Flow | -53.21 | 185.63 | -82.96 | 133.68 | 22.7 | -23.05 | Upgrade
|
| Free Cash Flow | -118.04 | -1.61 | -67.16 | -50.25 | -14.8 | -56.91 | Upgrade
|
| Free Cash Flow Margin | -258.21% | -3.49% | -162.19% | -136.04% | -42.97% | -279.46% | Upgrade
|
| Free Cash Flow Per Share | -2.33 | -0.04 | -1.80 | -1.75 | -1.15 | -5.46 | Upgrade
|
| Cash Interest Paid | - | 1.41 | 2.6 | 4.85 | 5.51 | 4.87 | Upgrade
|
| Levered Free Cash Flow | -59.13 | 15.77 | -38.27 | -27.22 | -14.81 | -53.8 | Upgrade
|
| Unlevered Free Cash Flow | -59.13 | 16.55 | -36.28 | -23.79 | -11.02 | -50.54 | Upgrade
|
| Change in Net Working Capital | 15.84 | -53.68 | 1.42 | -0.7 | -4.46 | 27.58 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.